Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

Windtree Therapeutics  / Equity Bottom-Up

<ul><li>Zacks Small-Cap Research Note for Windtree Therapeutics (WINT)</li></ul>

Zacks Small-Cap Research Note for Windtree Therapeutics (WINT)

WINT: Patient Enrollment in SEISMiC C Trial Starts, Patent Position Expands

WINT: Lead Drug Candidates, Multiple Programs, Several Upcoming Expected Milestones

United States

Windtree Therapeutics, Inc. operates as a clinical-stage biopharmaceutical and medical device company. The Company focuses on developing novel therapeutics for the treatment of patients with acute cardiovascular and pulmonary diseases. Windtree Therapeutics serves customers in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00